Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Measurement properties of the Activities-specific Balance Confidence (ABC) scale in community-dwelling adults aged 50 years and older: a COSMIN systematic review. | J Patient Rep Outcomes | 2026 | 42319626 | PubTator, text mining | PubMed |
| Use of genetic analysis in adult cholestatic liver disease: lessons from progressive paediatric syndromes and cohort studies. | Gut | 2026 | 42309808 | PubTator, text mining | PubMed |
| Clinical utility of an evolving cholestasis gene panel in 10,000 children and adults. | Front Pediatr | 2026 | 42232620 | PubTator, text mining | PubMed |
| A Molecular Mechanism of Intrahepatic Cholestasis in Osteo-Oto-Hepato-Enteric Syndrome. | Cell Mol Gastroenterol Hepatol | 2026 | 42167729 | PubTator, text mining | PubMed |
| Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD). | Eur J Pharmacol | 2026 | 42167668 | PubTator, text mining | PubMed |
| Tripterygium Glycosides Extract-Induced Hepatic Cholestasis: A Mechanistic Study Using a Microfluidic Liver-on-a-Chip System. | Int J Mol Sci | 2026 | 42123731 | PubTator, text mining | PubMed |
| Navigating the complexities of progressive familial intrahepatic cholestasis-II: Genetic insights, patient outcomes, and nursing implications - A case report. | J Pediatr Nurs | 2026 | 42119236 | PubTator, text mining | PubMed |
| In Silico Prediction of Potential Bile Salt Export Pump Inhibitors Using Pharmacophore Models and Consensus Machine Learning. | J Chem Inf Model | 2026 | 42028674 | PubTator, text mining | PubMed |
| Identification of 19 Pathogenic Variants in a Clinically Heterogeneous Cohort With Suspected Inborn Errors of Metabolism. | Clin Genet | 2026 | 41968882 | PubTator, text mining | PubMed |
| Does a degree in medicine or a specialist programme or socioeconomic status advance the career of general practitioners in primary healthcare? | PLoS One | 2026 | 41911306 | PubTator, text mining | PubMed |
| Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma. | Cancer Lett | 2026 | 41903671 | PubTator, text mining | PubMed |
| Psychometric properties of the Vertigo Handicap Questionnaire in the Spanish-speaking population. | J Vestib Res | 2026 | 41902518 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Reveals the Impact of SHEV ORF3-Related LncRNA Network on Bile Secretion Pathway (ko 04976) in HepG2 Cells. | Vet Sci | 2026 | 41893693 | PubTator, text mining | PubMed |
| Gut Microbiota-Bile Acid Axis in Type 2 Diabetes-Associated Gallbladder Diseases: Mechanisms and Therapeutic Potential. | Metabolites | 2026 | 41893361 | PubTator, text mining | PubMed |
| Generation of proliferative hESC-derived grape-clustered hepatocyte organoids with multipolar architecture as regenerative counterpart via synergy of YAP and IGF2 pathways. | Cell Death Dis | 2026 | 41888105 | PubTator, text mining | PubMed |
| Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury. | EBioMedicine | 2026 | 41880860 | PubTator, text mining | PubMed |
| When Birth Control Turns Biliary: A Rare Case of Profound Hyperbilirubinemia From Oral Contraceptives. | J Investig Med High Impact Case Rep | 2026 | 41873646 | PubTator, text mining | PubMed |
| Disordered Bile Acid Metabolism in Alcohol-Related Hepatitis. | Aliment Pharmacol Ther | 2026 | 41870486 | PubTator, text mining | PubMed |
| Odevixibat treatment for recurrent cholestasis in a patient with biallelic UNC45A variants causing osteo-oto-hepato-enteric syndrome. | JHEP Rep | 2026 | 41861679 | PubTator, text mining | PubMed |
| Advancing the bioassay ontology through integrated PK/PD and safety pharmacology representation. | J Biomed Semantics | 2026 | 41821121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=2